JPS5636418A - Bonded tissue self immunity disease treatment drug - Google Patents

Bonded tissue self immunity disease treatment drug

Info

Publication number
JPS5636418A
JPS5636418A JP11967880A JP11967880A JPS5636418A JP S5636418 A JPS5636418 A JP S5636418A JP 11967880 A JP11967880 A JP 11967880A JP 11967880 A JP11967880 A JP 11967880A JP S5636418 A JPS5636418 A JP S5636418A
Authority
JP
Japan
Prior art keywords
disease treatment
treatment drug
immunity disease
tissue self
bonded tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP11967880A
Other languages
Japanese (ja)
Inventor
Bikutoru Sukurifubuaazu Bo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of JPS5636418A publication Critical patent/JPS5636418A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP11967880A 1979-08-30 1980-08-28 Bonded tissue self immunity disease treatment drug Pending JPS5636418A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH787179 1979-08-30

Publications (1)

Publication Number Publication Date
JPS5636418A true JPS5636418A (en) 1981-04-09

Family

ID=4331669

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11967880A Pending JPS5636418A (en) 1979-08-30 1980-08-28 Bonded tissue self immunity disease treatment drug

Country Status (5)

Country Link
JP (1) JPS5636418A (en)
AU (1) AU545003B2 (en)
BE (1) BE884935A (en)
IT (1) IT1141027B (en)
PH (1) PH16864A (en)

Also Published As

Publication number Publication date
PH16864A (en) 1984-03-22
IT8024347A0 (en) 1980-08-28
IT1141027B (en) 1986-10-01
BE884935A (en) 1981-02-27
AU545003B2 (en) 1985-06-27
AU6183680A (en) 1981-03-19

Similar Documents

Publication Publication Date Title
FI880195A (en) THERAPEUTIC PRODUCT.
BE881351A (en) MEDICAL PREPARATION
DK360188D0 (en) MEDICINE DELIVERY BODY
JPS57131721A (en) Drug treatment for body disease
DK250088A (en) OPHTHALMOLOGICAL PREPARATION
DK28188D0 (en) MEDICAL DIAGNOSIS
JPS5630918A (en) Medical composition for skin disease
JPS57139016A (en) Burn patient medicine
NO880292L (en) PROCEDURE FOR HUMAN TREATMENT.
NO881303D0 (en) PATIENTS FOR PATIENT BED.
JPS54141797A (en) Therapeutic drug
GB2119734B (en) Encapsulated living tissue
GB8719361D0 (en) Medical syringe
JPS5636418A (en) Bonded tissue self immunity disease treatment drug
JPS5436083A (en) Medical catheter
JPS5683346A (en) Patient bed
JPS5622733A (en) Immunity creature therapeutic drug and its manufacture
JPS5636939A (en) Living body medical electrode
DK210187A (en) MEDICAL TAMPON
JPS5628744A (en) Physiological sense unit
GB2015873B (en) Medical treatment chair
DE3366025D1 (en) Medicine for the treatment of the neoplazic disease
JPS55158033A (en) Endoscope for medical treatment
JPS55166144A (en) Capsule for medical treatment
DK681288D0 (en) AENOOTROPT THERAPEUTIC MEDICINE